Max Wrobel

Max Wrobel is currently the Director of Global Markets at UBS, focusing on equities within systematic, data and platform sales for hedge funds and institutional family offices. Previously, Max held positions including Vice President at Credit Suisse and Associate at Van Lanschot Kempen, where they contributed to equity sales and capital markets transactions, notably the IPO of BioNTech. Max's earlier experience includes roles at Treehill Partners, Brown Advisory, and BTG plc, as well as academic achievements from institutions such as The Johns Hopkins University, The University of Edinburgh, and Sevenoaks School.